Metamark Genetics snags potential $365m cancer targets deal with Janssen
21 December 2011
Nancy Faigen
Please Login to read the full article.
21 December 2011
Nancy Faigen
nancy.faigen@informausa.com
Please Login to read the full article.
RELATED CONTENT
NEWS
- Genentech bonds with Constellation in epigenetics drug deal
- Third time's the charm for $100 million Merrimack IPO after two false starts
- US Capitol Capsule: Supreme Court takes another stab at refining US patent law
- Genentech in rare deal to buy preclinical tumour metabolism programme from Forma
ANALYSIS
Other Informa Analysis
COMMENT
Other Informa Comment
EVENTS
Today
Continental Zara Hotel, Budapest, Hungary
Today
Radisson Blu Royal Hotel, Dublin
Today
Hotel Sofitel Hamburg Alter Wall
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
